Relation between Hypofractionated Radiotherapy, Toxicity and Outcome in Early Breast Cancer
Author:
Affiliation:
1. Department of Radiotherapy; Policlinico Umberto I “Sapienza” University of Rome; Rome Italy
2. Spencer-Lorillard Foundation; Rome Italy
Publisher
Hindawi Limited
Subject
Oncology,Surgery,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/tbj.12792/fullpdf
Reference17 articles.
1. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis;Forouzanfar;Lancet,2011
2. National Comprehensive Cancer Network Guidelines Version 1.2016 Breast Cancer http://www.nccn.org
3. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials;Darby;Lancet,2011
4. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial;Bentzen;Lancet,2008
5. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial;Bentzen;Lancet Oncol,2008
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis;BMJ;2024-09-11
2. Adjuvant and Neoadjuvant Therapy for Breast Cancer: A Systematic Review;European Journal of Breast Health;2024-07-01
3. Efficacy and safety analysis of hypofractionated and conventional fractionated radiotherapy in postoperative breast cancer patients;BMC Cancer;2024-02-06
4. Hypofractionated whole breast irradiation in association with hypofractionated or normofractionated boost to the tumor bed in early breast cancer: tolerance and efficacy analysis;Clinical and Translational Oncology;2023-03-22
5. Whole-breast Radiotherapy With Boost for Node-negative Breast Cancer: Conventionalvs. Hypo-fractionation;In Vivo;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3